GleamWall
中文EN

CRON Cronos Group Inc.

Medicinal Chemicals & Botanical Products · Nasdaq · SEC CIK 1656472 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY55.8%
TTM net income YoY60.2%
TTM EPS YoY60.0%
Revenue 3-yr CAGR34.2%
Net income 3-yr CAGR—

Margins

Gross margin46.6%
Operating margin3.4%
Net margin28.0%
FCF margin31.7%
EBITDA margin7.4%

Returns

ROE5.4%
ROA4.9%
ROIC (approx.)1.5%
Asset turnover0.17x

Leverage & solvency

Liabilities / assets6.1%
Debt / equity0.00x
Current ratio12.71x
Interest coverage—

Cash quality & payout

Operating cash flow / net income1.40x
Accruals ratio-2.0%
Payout ratio—
Capex / revenue7.6%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$146.59M$117.61M
Gross profit$62.76M$25.20M
R&D expense$4.45M$4.23M
SG&A expense$42.00M$46.51M
Operating income-$17.39M-$76.53M
Pretax income-$17.12M$36.59M
Income tax-$14.19M-$3.44M
Net income-$9.45M$41.08M
EBITDA-$3.16M-$67.19M
EPS (basic)-0.020.11
EPS (diluted)-0.020.11
Weighted avg. shares (diluted)383.47M385.56M
Balance sheet
Cash & equivalents$791.79M$858.80M
Short-term investments$40.00M$0
Receivables$34.10M$15.46M
Inventory$46.75M$33.15M
Current assets$944.09M$936.11M
PP&E, net$145.87M$133.19M
Goodwill$66.48M$63.45M
Intangibles$8.89M$11.26M
Total assets$1.20B$1.17B
Current liabilities$48.19M$49.70M
Total liabilities$54.18M$55.33M
Shareholders' equity$1.09B$1.06B
Shares outstanding381.59M382.53M
Cash flow statement
Operating cash flow$25.87M$18.84M
Capital expenditure$25.72M$12.41M
Free cash flow$149,000$6.43M
Investing cash flow-$76.56M$175.15M
Financing cash flow-$19.91M-$1.23M
Depreciation & amortization$14.23M$9.34M
Stock-based compensation$7.05M$8.70M
Share buybacks$9.74M$0

Free plan shows the latest 2 periods; Pro shows all 10 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.